Screenin3d Limited (sc614453) is a private limited with share capital incorporated on 22/11/2018 (7 years old) and registered in glasgow, G11RD. The company operates under SIC code 72110 and is classified as Micro.
Precision medicine and drug development based on maximising screening of limited human cancerous tissue in 3d with microfluidic technology.
Change Corporate Director Company With Change Date
Category:Officers
Date:27-11-2023
Change Corporate Director Company With Change Date
Category:Officers
Date:27-11-2023
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:23-11-2023
Appoint Corporate Director Company With Name Date
Category:Officers
Date:23-08-2023
Capital Allotment Shares
Category:Capital
Date:07-08-2023
Capital Alter Shares Subdivision
Category:Capital
Date:03-08-2023
Capital Allotment Shares
Category:Capital
Date:03-08-2023
Memorandum Articles
Category:Incorporation
Date:03-08-2023
Resolution
Category:Resolution
Date:03-08-2023
Resolution
Category:Resolution
Date:01-08-2023
Notification Of A Person With Significant Control
Category:Persons With Significant Control
Date:26-07-2023
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:28-03-2023
Confirmation Statement With Updates
Category:Confirmation Statement
Date:25-11-2022
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:25-11-2022
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:25-04-2022
Change Person Director Company With Change Date
Category:Officers
Date:05-04-2022
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:26-11-2021
Confirmation Statement With Updates
Category:Confirmation Statement
Date:26-11-2021
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:25-11-2021
Change Person Director Company With Change Date
Category:Officers
Date:25-11-2021
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:04-10-2021
Accounts With Accounts Type Unaudited Abridged
Category:Accounts
Date:29-06-2021
Accounts Amended With Made Up Date
Category:Accounts
Date:21-01-2021
Confirmation Statement With Updates
Category:Confirmation Statement
Date:24-11-2020
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:24-11-2020
Change Person Director Company With Change Date
Category:Officers
Date:29-10-2020
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:26-10-2020
Accounts With Accounts Type Unaudited Abridged
Category:Accounts
Date:26-10-2020
Change Account Reference Date Company Previous Extended
Category:Accounts
Date:20-07-2020
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:02-12-2019
Incorporation Company
Category:Incorporation
Date:22-11-2018
Innovate Grants
1
This company received a grant of £101564.0 for A Novel Therapeutic Antibody To Improve Cancer Treatment Through The Elimination Of Senescent Cells. The project started on 01/06/2022 and ended on 31/05/2024.
Risk Assessment
low risk
International Score
Future Factor
excellent
Performance Rating
Accounts
Typeunaudited abridged
Due Date30/09/2027
Filing Date13/04/2026
Latest Accounts31/12/2025
Trading Addresses
Technology And Innovation Centre, 99 George Street, Glasgow, G1 1Rd, G11RDRegistered